Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003)

被引:13
作者
Michiels, B [1 ]
Philips, H [1 ]
Coenen, S [1 ]
Denekens, J [1 ]
Van Royen, P [1 ]
机构
[1] Univ Antwerp, Ctr Gen Pract, B-2610 Antwerp, Belgium
关键词
influenza vaccines; general practitioner; antibodies;
D O I
10.1016/j.vaccine.2006.01.040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Efficacy studies have not answered the question whether influenza vaccination among general practitioners (GPs) has a substantial additive effect on their immunity. To evaluate this effect the influenza antibody titres in vaccinated and unvaccinated GPs were compared in a controlled trial during two consecutive winter periods (2002-2003 and 2003-2004). The seroprotection rates against the circulating A/H3N2 influenza virus amount to 80% and 42% in the unvaccinated group in 2002 and 2003, respectively. In the vaccinated GPs the seroprotection rate increases from 91% to 96% in 2002 and from 70% to 83% in 2003 after vaccination. Besides vaccination, the (high) basic antibody titre before vaccination and working in a child and family preventive medicine unit were predicting a protective antibody level in GPs. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3145 / 3152
页数:8
相关论文
共 25 条
[1]   Approaches to improved influenza vaccination [J].
Betts, RF ;
Treanor, JJ .
VACCINE, 2000, 18 (16) :1690-1695
[2]   Protection against influenza after annually repeated vaccination -: A meta-analysis of serologic and field studies [J].
Beyer, WEP ;
de Bruijn, IA ;
Palache, AM ;
Westendorp, RGJ ;
Osterhaus, ADME .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (02) :182-188
[3]  
CLEMENTS ML, 1984, LANCET, V1, P705
[4]   Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine [J].
Greenbaum, E ;
Engelhard, D ;
Levy, R ;
Schlezinger, M ;
Morag, A ;
Zakay-Rones, Z .
VACCINE, 2004, 22 (20) :2566-2577
[5]   Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination [J].
Gulati, U ;
Kumari, K ;
Wu, W ;
Keitel, WA ;
Air, GM .
VACCINE, 2005, 23 (11) :1414-1425
[6]   Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults [J].
Halperin, Scott A. ;
Smith, Bruce ;
Clarke, Kevin ;
Treanor, John ;
Mabrouk, Taoufik ;
Germain, Marc .
HUMAN VACCINES, 2005, 1 (01) :37-42
[7]  
Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1
[8]   Ten years of experience with the trivalent split-influenza vaccine, Fluarix™ [J].
Hehme, NW ;
Künzel, W ;
Petschke, F ;
Türk, G ;
Raderecht, C ;
van Hoecke, C ;
Sänger, R .
CLINICAL DRUG INVESTIGATION, 2002, 22 (11) :751-769
[9]   Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period [J].
Keitel, WA ;
Cate, TR ;
Couch, RB ;
Huggins, LL ;
Hess, KR .
VACCINE, 1997, 15 (10) :1114-1122
[10]  
Kleinbaum DG., 2002, Logistic Regression: A Self-Learning Text